IL131004A0 - Il-8 receptor antagonists - Google Patents
Il-8 receptor antagonistsInfo
- Publication number
- IL131004A0 IL131004A0 IL13100498A IL13100498A IL131004A0 IL 131004 A0 IL131004 A0 IL 131004A0 IL 13100498 A IL13100498 A IL 13100498A IL 13100498 A IL13100498 A IL 13100498A IL 131004 A0 IL131004 A0 IL 131004A0
- Authority
- IL
- Israel
- Prior art keywords
- receptor antagonists
- antagonists
- receptor
- Prior art date
Links
- 102000010681 interleukin-8 receptors Human genes 0.000 title 1
- 108010038415 interleukin-8 receptors Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65848—Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3599197P | 1997-01-23 | 1997-01-23 | |
US4282997P | 1997-04-08 | 1997-04-08 | |
PCT/US1998/001291 WO1998032439A1 (en) | 1997-01-23 | 1998-01-23 | Il-8 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IL131004A0 true IL131004A0 (en) | 2001-01-28 |
Family
ID=26712688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13100498A IL131004A0 (en) | 1997-01-23 | 1998-01-23 | Il-8 receptor antagonists |
Country Status (15)
Country | Link |
---|---|
US (1) | US6300325B1 (xx) |
EP (1) | EP0991406A4 (xx) |
JP (1) | JP2001511130A (xx) |
KR (1) | KR20000070368A (xx) |
CN (1) | CN1217660C (xx) |
AU (1) | AU726858B2 (xx) |
BR (1) | BR9807083A (xx) |
CA (1) | CA2278504A1 (xx) |
HU (1) | HUP0001943A3 (xx) |
IL (1) | IL131004A0 (xx) |
NO (1) | NO313961B1 (xx) |
NZ (1) | NZ336861A (xx) |
PL (1) | PL334756A1 (xx) |
TR (1) | TR199901710T2 (xx) |
WO (1) | WO1998032439A1 (xx) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6218539B1 (en) | 1996-06-27 | 2001-04-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
EP1087661A4 (en) * | 1998-06-17 | 2003-04-16 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
DE19842363A1 (de) * | 1998-09-16 | 2000-03-30 | Forssmann Wolf Georg | Verwendung von Chemokinen zur Stammzellmobilisation und von Chemokin-Antagonisten zur Vermeidung von Tumormetastasierung |
EP1158985B1 (en) | 1999-01-13 | 2011-12-28 | Bayer HealthCare LLC | OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
CO5170514A1 (es) * | 1999-05-28 | 2002-06-27 | Smithkline Beecham Corp | Antagonistas de los receptores de la il-8 nistas del receptor de la il-8 |
CO5190696A1 (es) * | 1999-06-16 | 2002-08-29 | Smithkline Beecham Corp | Antagonistas de los receptores il-8 |
DE10038709A1 (de) * | 2000-08-09 | 2002-02-28 | Aventis Pharma Gmbh | Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen |
US20030204085A1 (en) * | 2001-02-02 | 2003-10-30 | Taveras Arthur G. | 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists |
US7132445B2 (en) * | 2001-04-16 | 2006-11-07 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
US6867222B2 (en) | 2001-04-18 | 2005-03-15 | Euro-Celtique, S.A. | Nociceptin analogs |
WO2003031440A1 (en) * | 2001-10-12 | 2003-04-17 | Schering Corporation | 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
US6878709B2 (en) * | 2002-01-04 | 2005-04-12 | Schering Corporation | 3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
AU2003209119A1 (en) | 2002-02-11 | 2003-09-04 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
SI1478358T1 (sl) | 2002-02-11 | 2013-09-30 | Bayer Healthcare Llc | Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi |
US20040053953A1 (en) * | 2002-03-18 | 2004-03-18 | Schering Corporation | Treatment of chemokine mediated diseases |
US7115644B2 (en) * | 2002-09-13 | 2006-10-03 | Boehringer Ingelheim Pharmaceuticals Inc. | Heterocyclic compounds |
ES2321186T3 (es) * | 2002-10-09 | 2009-06-03 | Schering Corporation | Dioxidos de tiadiazol y monoxidos de tiadiazol como ligandos de los receptores de quimioquinas cxc y cc. |
AR041834A1 (es) * | 2002-10-29 | 2005-06-01 | Smithkline Beecham Corp | Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion |
DK1636585T3 (da) | 2003-05-20 | 2008-05-26 | Bayer Pharmaceuticals Corp | Diarylurinstoffer med kinasehæmmende aktivitet |
CL2004001834A1 (es) | 2003-07-23 | 2005-06-03 | Bayer Pharmaceuticals Corp | Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol |
ATE406356T1 (de) * | 2003-12-19 | 2008-09-15 | Schering Corp | Thiadiazole als cxc- und cc- chemokinrezeptorliganden |
WO2005068460A1 (en) * | 2003-12-22 | 2005-07-28 | Schering Corporation | Isothiazole dioxides as cxc- and cc- chemokine receptor ligands |
GB0403038D0 (en) | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
JP2007537272A (ja) | 2004-05-12 | 2007-12-20 | シェーリング コーポレイション | Cxcr1およびcxcr2ケモカインアンタゴニスト |
US20070249625A1 (en) * | 2004-10-20 | 2007-10-25 | Jakob Busch-Petersen | Il-8 Receptor Antagonists |
EP1809619A1 (en) * | 2004-10-21 | 2007-07-25 | Transtech Pharma, Inc. | Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
JP2009500328A (ja) * | 2005-06-29 | 2009-01-08 | シェーリング コーポレイション | Cxc−ケモカインレセプターリガンドとしての5,6−ジ−置換オキサジアゾロピラジンおよびチアジアゾロピラジン |
WO2007002764A2 (en) * | 2005-06-29 | 2007-01-04 | Schering Corporation | Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
KR101376472B1 (ko) * | 2006-04-21 | 2014-03-19 | 글락소스미스클라인 엘엘씨 | Il8 수용체 길항제 |
WO2007124423A2 (en) * | 2006-04-21 | 2007-11-01 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
TW200817006A (en) * | 2006-06-23 | 2008-04-16 | Smithkline Beecham Corp | IL-8 receptor antagonist |
WO2008005570A1 (en) * | 2006-07-07 | 2008-01-10 | Schering Corporation | 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
WO2011023081A1 (en) | 2009-08-24 | 2011-03-03 | Ascepion Pharmaceuticals, Inc. | 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
CN111362878B (zh) * | 2020-03-18 | 2023-09-19 | 湖南复瑞生物医药技术有限责任公司 | 一种4-氨基-1,3-二氢-苯并咪唑-2-酮的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK160941C (da) | 1988-06-28 | 1991-10-21 | Novo Nordisk As | Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar |
EP0809492A4 (en) * | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
JP2000513359A (ja) * | 1996-06-27 | 2000-10-10 | スミスクライン・ビーチャム・コーポレイション | Il―8受容体拮抗薬 |
JP2000515495A (ja) * | 1996-06-27 | 2000-11-21 | スミスクライン・ビーチャム・コーポレイション | Il―8レセプターアンタゴニスト |
-
1998
- 1998-01-23 CA CA002278504A patent/CA2278504A1/en not_active Abandoned
- 1998-01-23 KR KR1019997006601A patent/KR20000070368A/ko not_active Application Discontinuation
- 1998-01-23 PL PL98334756A patent/PL334756A1/xx unknown
- 1998-01-23 EP EP98905988A patent/EP0991406A4/en not_active Withdrawn
- 1998-01-23 TR TR1999/01710T patent/TR199901710T2/xx unknown
- 1998-01-23 IL IL13100498A patent/IL131004A0/xx unknown
- 1998-01-23 CN CN988035650A patent/CN1217660C/zh not_active Expired - Fee Related
- 1998-01-23 JP JP53213898A patent/JP2001511130A/ja not_active Ceased
- 1998-01-23 US US09/341,378 patent/US6300325B1/en not_active Expired - Fee Related
- 1998-01-23 WO PCT/US1998/001291 patent/WO1998032439A1/en not_active Application Discontinuation
- 1998-01-23 NZ NZ336861A patent/NZ336861A/xx unknown
- 1998-01-23 BR BR9807083-5A patent/BR9807083A/pt not_active Application Discontinuation
- 1998-01-23 HU HU0001943A patent/HUP0001943A3/hu unknown
- 1998-01-23 AU AU61339/98A patent/AU726858B2/en not_active Ceased
-
1999
- 1999-07-22 NO NO19993586A patent/NO313961B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0991406A1 (en) | 2000-04-12 |
US6300325B1 (en) | 2001-10-09 |
NO313961B1 (no) | 2003-01-06 |
AU6133998A (en) | 1998-08-18 |
HUP0001943A3 (en) | 2002-12-28 |
NO993586L (no) | 1999-09-21 |
CN1251038A (zh) | 2000-04-19 |
AU726858B2 (en) | 2000-11-23 |
KR20000070368A (ko) | 2000-11-25 |
NO993586D0 (no) | 1999-07-22 |
EP0991406A4 (en) | 2000-12-13 |
CA2278504A1 (en) | 1998-07-30 |
HUP0001943A2 (hu) | 2001-01-29 |
PL334756A1 (en) | 2000-03-13 |
CN1217660C (zh) | 2005-09-07 |
WO1998032439A1 (en) | 1998-07-30 |
TR199901710T2 (xx) | 1999-09-21 |
BR9807083A (pt) | 2000-04-18 |
JP2001511130A (ja) | 2001-08-07 |
NZ336861A (en) | 2001-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA988100B (en) | IL-8 receptor antagonists | |
IL131004A0 (en) | Il-8 receptor antagonists | |
IL127666A0 (en) | IL-8 receptor antagonists | |
IL127667A0 (en) | IL-8 receptor antagonists | |
EP0932405A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP0896531A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
IL128501A0 (en) | IL-8 receptor antagonists | |
EP1000017A4 (en) | ANTAGONISTS OF THE IL-8 RECEPTOR | |
EP1019035A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP0907362A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP0920417A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
IL131005A0 (en) | Il-8 receptor antagonists | |
HK1028730A1 (en) | Il-8 receptor antagonists | |
EP0971908A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP0923373A4 (en) | IL-8 RECEPTOR ANTAGOISTS | |
EP0957907A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP0939634A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP0934066A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP1039903A4 (en) | INTERLEUKIN-8 RECEPTOR ANTAGONISTS | |
EP1047424A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP0920253A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP0948330A4 (en) | COOLING ANTENNA WITH CURVED SEGMENTS | |
PL346178A1 (en) | Il-8 receptor antagonists | |
ZA98519B (en) | Il-8 receptor antagonists | |
HUP9904303A3 (en) | Il-8 receptor antagonists |